Form-4 Alert, Fresh Options Plays

Nkarta, Inc. NKTX – Form-4 Alert

We took notice of an interesting new IPO this morning in NKTX. Typically we would be more interested in stocks with a long history of data to look at, but in this case a notable name is buying up shares. Mega-laboratory GlaxoSmithKline purchased a noteworthy $15M chunk of NKTX, and the newly issued stock has been in a freefall looking for support.

In our experience, we see a lot of IPO’s that sell off hard directly after their initial offering just like this one. It’s when they establish a firm bottom that the buying opportunity is at its greatest, so we are definitely going to want to keep a close watch over NKTX for that to occur. There may be a solid gain opportunity on the horizon here that we won’t want to miss.


Virgin Galactic Holdings Inc. SPCE

We highlighted some calls in SPCE last week and met with great success, to the tune of several multi-bag gain opportunites. It has continued to run this week, and so far we’ve seen a 39% move in the stock alone from 19.07-23.53.

We are interested in selecting another range of calls to monitor with SPCE faring so well, so we’re going to place the SPCE $25.50-26.50 Calls on watch for the remainder of the week.


GeoVax Labs, Inc. GOVX

We tagged GOVX in our
extended watchlist on Tuesday, and this stock has made an absolutely eye-popping move.

From its low of .62 on Tuesday, GOVX hit 1.75 yesterday, marking a total two-day upswing of 182% We’ll continue to keep an eye peeled for more activity in this highly volatile play.


Options Ideas:
KMB Weekly $145-148 Calls
DHR 08/21 $200-210 Calls 


Extended Watchlist:
MSTO, WNDW, VYST, TSOI, LTUM

ADMQ Special Report

ADM Endeavors Inc. (OTCMKTS:ADMQ)

As we do on occasion, we’re taking a momentary break from our typical options interests this morning to bring you a special report spotlighting what we feel is a stock that is worthy of our attention. Our regular readers are certainly aware that we often look to diversify our radar screens by seeking out interesting OTC-traded stocks, and that’s what we have in ADMQ.

Especially with OTC plays, we’re always looking for a relatively tight share structure, which gives the stock a greater ability to make the kind of significant upswings that traders are after. We have that in this case, with ADMQ having just 138,670,000 shares outstanding and 53,270,000 in the float.

Sometimes OTC-traded symbols can represent companies that are little more than shells, existing only on paper, but such is not the case with ADMQ, which logged $3.8M in sales last year. That is a majority percentage of the company’s current market cap, which is why we feel strongly that this stock is undervalued at the present time and worth a spot on our watchlist.

ADMQ has operated a diverse practical application graphics business in the Dallas/Fort Worth area since 2010, its motto is “We sell anything with a logo!”, and it has various ways of accomplishing this. The company has sales, screen printing, embroidery, digital production, wholesale sourcing, and uniform divisions, through its wholly owned subsidiary, Just Right Products, Inc., as well as other brand names and web properties. While some businesses have struggled during the coronavirus pandemic, ADMQ is reporting an increase in business.

ADMQ has been meeting demand for personal protective equipment with mask requirements at most places where people congregating. It has printed cotton masks and other apparel available at 247365threads.com, while its main design printing web property is located at FWPromo.com.

We are as excited about the potential that ADMQ stock currently boasts as any OTC stock we’ve covered this year, and as many of you know, there have been quite a few major winners. 


ADMQ CHART: 

As we mentioned above, we feel ADMQ is currently undervalued. The stock is trading near its 52-week lows, and with the tight share structure here, a relatively small amount of buying pressure could send the stock significantly higher. As we also mentioned above, we’ve seen plenty of OTC breakout plays in recent months, and ADMQ could be the next in line to make a big push off of these lows.


ADMQ VIDEO:

We would like to suggest at the very least, that you add the following video (13:40 runtime) to your YouTube playlist, and come back to check it out when you get the chance. Or do it now! It’s a detailed view of the company’s production facility and processes, as featured on the “Preston” YouTube channel, which has over 13 million active subscribers. 

View ADMQ Video 


Interested in More Information on ADMQ?
Please visit ADMEndeavors.com
or contact Peter Nicosia at (585)703-6565

Big Winners, More New Ideas

iBio, Inc IBIO – Update

It was just this past Thursday morning that we were mentioning our great success in tracking IBIO to multibag gains, beginning when we first highlighted it as a potential coronavirus play on March 17th. We subsequently observed a low of .76, and as of our followup last week, it had produced an increase of over 400%

That was before yesterday, in which IBIO took the #3 top gainer spot on the NASDAQ, and broke out to yet another impressive new high of 7.43. That extends the gain we’ve seen on this play since our initial alert to a mammoth 878%  Even as other stocks representing COVID-19 vaccine candidates have been flagging of late, IBIO has continued its impressive uptrend, and we’re excited to see where it goes from here.


Microsoft Inc. MSFT

One of our options ideas from yesterday morning’s report fared quite well during the session, and based on the way things look in the premarket today, we expect to see further increases in our target contracts.

Those were the MSFT Weekly $205-210 Calls and they got off to a really good start with some solid intraday gains: 

MSFT Weekly $205-210 Calls
$205: 6.70-11.30 (+69%)
$207.50: 5.65-10.10 (+79%)
$19: 4.75-8.75 (+84%)

We also want to roll up to include the MSFT Weekly $212.50-215 Calls in our watchlist.
______

Fresh Options Ideas:
PM Weekly $74.50-76 Calls
LMT Weekly $370-380 Calls
IBM Weekly $130-132 Calls
PLD 08/21 $100-105 Calls


Rising Biosciences, Inc. RBII

Another mention from yesterday morning’s premarket report was RBII, and that too exhibited a very nice move on the day.

We have been bringing some of our focus back to OTC stocks quite a bit more in 2020, and this is another in a growing line of solid calls on that front. The stock traded from a low of .003 mand went on to hit .0068, for an intraday rip of 127%


Extended Watchlist:
SBFM, GOVX, TTCM, VRUS, CYDY